Sandra Milligan

Insider Reports History

Entity
Individual
Location
2000 Galloping Hill Road, Kenilworth, NJ
Signature
/s/ Jeff Boerneke, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sandra Milligan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Organon & Co. Head of Research & Development Common Stock 28.6K $616K $21.53 May 4, 2023 Direct
Organon & Co. Head of Research & Development Restricted Stock Units 4.98K $107K $21.53 May 4, 2023 Direct
Aspira Women's Health Inc. President EMPLOYEE STOCK OPTION (RIGHT TO BUY) 30K $96K $3.20 May 3, 2024 Direct
Gossamer Bio, Inc. Director Common Stock 32K $25.2K $0.79 Nov 15, 2023 By family trust
Gossamer Bio, Inc. Director Non-qualified stock option (Right to Buy) 115K Jun 6, 2024 Direct
Spyre Therapeutics, Inc. Director Stock Option (Right to Buy) 22K May 14, 2024 Direct

Insider Reports Filed by Sandra Milligan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GOSS Gossamer Bio, Inc. Jun 6, 2024 1 $0 4 Jun 6, 2024 Director
SYRE Spyre Therapeutics, Inc. May 14, 2024 1 $0 4 May 16, 2024 Director
SYRE Spyre Therapeutics, Inc. May 14, 2024 0 $0 3 May 16, 2024 Director
AWH Aspira Women's Health Inc. May 3, 2024 1 $0 4 May 6, 2024 President
AWH Aspira Women's Health Inc. Apr 1, 2024 0 $0 3 Apr 4, 2024 President
GOSS Gossamer Bio, Inc. Nov 15, 2023 1 $25.2K 4 Nov 17, 2023 Director
GOSS Gossamer Bio, Inc. Jun 8, 2023 1 $0 4 Jun 9, 2023 Director
OGN Organon & Co. May 4, 2023 3 -$52.6K 4 May 8, 2023 Head of Research & Development
OGN Organon & Co. May 1, 2023 3 -$20.3K 4 May 3, 2023 Head of Research & Development
OGN Organon & Co. Mar 31, 2023 5 -$48.8K 4 Apr 4, 2023 Head of Research & Development
OGN Organon & Co. Feb 28, 2023 3 -$58.9K 4 Mar 2, 2023 Head of Research & Development
GOSS Gossamer Bio, Inc. Jun 9, 2022 1 $0 4 Jul 15, 2022 Director
OGN Organon & Co. May 3, 2022 6 -$75.4K 4 May 5, 2022 Head of Research & Development
OGN Organon & Co. May 1, 2022 3 -$17.5K 4 May 3, 2022 Head of Research & Development
OGN Organon & Co. Mar 31, 2022 2 $0 4 Apr 4, 2022 Head of Research & Development
OGN Organon & Co. Feb 28, 2022 3 -$110K 4 Mar 2, 2022 Head of Research & Development
OGN Organon & Co. Aug 17, 2021 1 $0 4 Aug 19, 2021 Head of Research & Development
GOSS Gossamer Bio, Inc. Jun 10, 2021 1 $0 4 Jun 14, 2021 Director
GOSS Gossamer Bio, Inc. Jun 10, 2021 0 $0 3 Jun 14, 2021 Director
OGN Organon & Co. Jun 2, 2021 12 $0 4 Jun 4, 2021 Head of Research & Development
OGN Organon & Co. Jun 2, 2021 0 $0 3 Jun 2, 2021 Head of Research & Development